TITLE
Combination targeted therapy to disrupt aberrant oncogenic signaling and reverse epigenetic dysfunction in IDH2- and TET2-mutant acute myeloid leukemia

ORGANISM
Mus musculus

SUMMARY
This SuperSeries is composed of the SubSeries listed below.

DESIGN
Refer to individual Series

PLATFORM
GPL13112 Illumina HiSeq 2000 (Mus musculus)

CITATIONS
28193779

